Specialty Technologies? Meet Metrics.
Our proprietary advanced drug delivery technologies are available through licensing or co-development arrangements. What problem can we help you solve?
Liquids, creams and gels now available.
In addition to solid oral dosage forms, Metrics can now produce a range of non-sterile liquids and topicals.
A CDMO that will earn your confidence.
A scientist to lead your project, full analytical support to keep it on track, and a veteran team to complete it successfully. That’s the Metrics promise.
Pharmaceutical drug product development
Metrics delivers pharmaceutical formulation development for routine or complex compounds, first time in man (FTIM) and fast-track development for a variety of dosage forms.
Method development, validation and stability testing
Metrics’ cGMP analytical testing facility has dedicated labs for stability studies, raw materials, trace metals, and microbiology.
CTM Manufacturing and commercial manufacturing
Metrics extends its scientist-led development and analytical testing of solid oral dose formulations into manufacturing for Phase I, II and III clinical trial material and commercialization.
Cleantaste™
Our new proprietary technology can improve the taste and stability of tablets; deliver sustained release characteristics.
Learn moreSUBA™ for enhanced bioavailability
Benefits of this new proprietary technology include improved and consistent drug absorption.
Learn moreLiquids, creams and gels
Metrics now produces non-sterile liquids, creams and gels for a broad range of applications.
Learn moreMetrics Offers Proprietary Pellet Forms
Metrics Inc. now offers proprietary pellet technologies enabling controlled release to help support therapeutic effectiveness of active pharmaceutical ingredients (API).
Learn moreUsing Quality by Design to Improve Tablet Strength
and Friability
Joe Cobb and his team used the principles of QbD to improve the robustness of a core tablet for a novel modified release oral solid dosage form. View the AAPS 2012 poster and watch a short video about how Metrics applies the principles of QbD to solve formulation development issues.
Read PosterMetrics Senior Scientists Receive Promotions
The recent acquisition by Mayne Pharma has paved the way for new leadership opportunities for several veteran scientists at Metrics. Senior scientists Dr. Brad Gold, Joe Cascone and Joe Cobb have been promoted to new roles at Metrics.
Learn moreMetrics expands capabilities for Phase I clinical trial materials
Metrics’ potent facility now offers neat API Capsule Filling. The completely contained Xcelodose® could help accelerate clients’ move to Phase I clinical trials.
Learn MoreSample Submittal Form
Sending a sample to Metrics?
Use this form to record your sample, storage and testing information.